Palmer B D, van Zijl P, Denny W A, Wilson W R
Cancer Research Laboratory, University of Auckland School of Medicine, New Zealand.
J Med Chem. 1995 Mar 31;38(7):1229-41. doi: 10.1021/jm00007a019.
5-[N,N-Bis(2-chloroethyl)amino]-2,4-dinitrobenzamide (1; SN 23862) is a novel bioreductive drug whose selective toxicity for hypoxic cells appears due to oxygen-inhibited enzymatic reduction of one of the nitro groups to the corresponding amine or hydroxylamine. Radiolytic reduction of 1 using up to four reducing equivalents in 1 N sodium formate was shown to proceed via electron addition to the 4-nitro group, thereby identifying this substituent as the most electron-affinic site in the molecule. The initially-formed 4-hydroxylamine and its N-hydroxytetrahydroquinoxaline half-mustard cyclization product (formed by intramolecular reaction with one arm of the adjacent mustard group) are reduced to the corresponding 4-amines upon further addition of electrons, although reduction of the 2-nitro group leading to 2,4-diamino products begins after addition of only six electron equivalents. Radiolytic reduction of the structurally similar 5-(aziridin-1-yl)-2,4-dinitrobenzamide (2; CB 1954) with six electron equivalents also occurs at the 4-nitro group to give the 4-hydroxylamine and 4-amine. The product mixture from reduction of 2 is less complex, largely because the corresponding 4-hydroxylamine and 4-amine are stable. The major reduction products of 1 were chemically synthesized by unequivocal routes to provide authentic samples for identification of the products of radiolytic reduction and to allow determination of their cytotoxicities. The 2- and 4-amino derivatives of 1 are significantly more cytotoxic than the parent drug, although the toxicity of the 4-amine is moderated by its facile conversion to the corresponding less toxic tetrahydroquinoxaline half-mustard. Although the 2- and 4-hydroxylamino derivatives were prepared by chemical reduction of 1, their toxicity could not be evaluated because of their instability. The 4-hydroxylamine reacts intramolecularly with the 5-mustard group somewhat more rapidly than does the 4-amine, while the 2-hydroxylamine is converted into a 2,2'-azoxy dimer following aerial oxidation to the 2-nitroso derivative. The fully reduced 2,4-diamino derivative of 1 is 10-fold more cytotoxic again than the 2-amine and, surprisingly, does not undergo spontaneous intramolecular alkylation. This elucidation of the reduction chemistry of 1 will facilitate further investigations of the toxic products generated from this compound both by hypoxic tumor cells and by ADEPT enzymes.
5-[N,N-双(2-氯乙基)氨基]-2,4-二硝基苯甲酰胺(1;SN 23862)是一种新型的生物还原药物,其对缺氧细胞的选择性毒性似乎是由于其中一个硝基被氧抑制的酶促还原为相应的胺或羟胺所致。在1 N甲酸钠中使用多达四个还原当量对1进行辐射还原,结果表明是通过向4-硝基添加电子来进行的,从而确定该取代基是分子中最亲电子的位点。最初形成的4-羟胺及其N-羟基四氢喹喔啉半芥子环化产物(通过与相邻芥子基团的一个臂进行分子内反应形成)在进一步添加电子后被还原为相应的4-胺,尽管在仅添加六个电子当量后就开始了导致2,4-二氨基产物的2-硝基的还原。结构类似的5-(氮丙啶-1-基)-2,4-二硝基苯甲酰胺(2;CB 1954)在六个电子当量下的辐射还原也发生在4-硝基上,生成4-羟胺和4-胺。2的还原产物混合物不太复杂,主要是因为相应的4-羟胺和4-胺是稳定的。通过明确的路线化学合成了1的主要还原产物,以提供用于鉴定辐射还原产物的真实样品,并确定它们的细胞毒性。1的2-和4-氨基衍生物的细胞毒性明显高于母体药物,尽管4-胺的毒性因其容易转化为相应毒性较小的四氢喹喔啉半芥子而有所缓和。尽管2-和4-羟氨基衍生物是通过1的化学还原制备的,但由于它们的不稳定性,无法评估它们的毒性。4-羟胺与5-芥子基团的分子内反应比4-胺稍快,而2-羟胺在空气中氧化为2-亚硝基衍生物后转化为2,2'-偶氮氧基二聚体。1的完全还原的2,4-二氨基衍生物的细胞毒性比2-胺再次高10倍,令人惊讶的是,它不会发生自发的分子内烷基化。对1的还原化学的这一阐明将有助于进一步研究由缺氧肿瘤细胞和ADEPT酶从该化合物产生的有毒产物。